Dr. Daruka Mahadevan named director of the Institute for Drug Development

October 7, 2020

Daruka Mahadevan, MD, PhD, chief of the Division of Hematology-Oncology, was appointed to two new expanded leadership roles at the Mays Cancer Center. In addition to being chief of hematology-oncology, Dr. Mahadevan will assume the roles of director of the Institute for Drug Development and associate director for clinical research. Dr. Mahadevan is a world-renowned expert in […]




Ruben Mesa, M.D., FACP, named executive director of the Mays Cancer Center

September 28, 2020

SAN ANTONIO (Sept. 28, 2020) — Ruben Mesa, MD, FACP, has been named executive director of the Mays Cancer Center. His appointment includes academic and research programming, as well as leading the cancer center’s patient care and clinical programs of the UT Health San Antonio MD Anderson affiliation. Dr. Mesa’s appointment broadens the scope of […]